Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA (Princeton Studies in American Politics: Historical, International, and Comparative Perspectives): 111 - Image 1

£38.58

Princeton University Press Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA (Princeton Studies in American Politics: Historical, International, and Comparative Perspectives): 111

Name: Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA (Princeton Studies in American Politics: Historical, International, and Comparative Perspectives): 111
Brand: Princeton University Press
Price: 38.58 GBP
Availability: InStock

Business & Economic History

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£39 today · all-time low £38 (Apr 2026) · usually £44

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 76 days • 76 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 76 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £38 (37 days, 48.7%)

Price range: £38 - £50

Price levels: 4 different prices over 76 days

Description

How the FDA became the world's most powerful regulatory agency The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Daniel Carpenter describes how the FDA cultivated a reputation for competence and vigilance throughout the last century, and how this organizational image has enabled the agency to regulate an industry as powerful as American pharmaceuticals while resisting efforts to curb its own authority. Carpenter explains how the FDA's reputation and power have played out among committees in Congress, and with drug companies, advocacy groups, the media, research hospitals and universities, and governments in Europe and India. He shows how FDA regulatory power has influenced the way that business, medicine, and science are conducted in the United States and worldwide. Along the way, Carpenter offers new insights into the therapeutic revolution of the 1940s and 1950s; the 1980s AIDS crisis; the advent of oral contraceptives and cancer chemotherapy; the rise of antiregulatory conservatism; and the FDA's waning influence in drug regulation today. Reputation and Power demonstrates how reputation shapes the power and behavior of government agencies, and sheds new light on how that power is used and contested.

Key Features

New

Mint Condition

Dispatch same day for order received before 12 noon

Guaranteed packaging

No quibbles returns

Product Specifications

Brand: Princeton University Press
Format: paperback
ASIN: 0691141800
Category: Books > Subjects > Business, Finance & Law > Biographies & Histories > Business & Economic History
Domain: Amazon UK
Release Date: 29 April 2010
Listed Since: 20 November 2008

Barcode

No barcode data available

Princeton University Press Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA (Princeton Studies in American Politics: Historical, International, and Comparative Perspectives): 111

About as cheap as it gets. The only time it was cheaper was 3 months ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Chembiomolecular Science: At the Frontier of Chemistry and Biology

An Overview of FDA Regulated Products: From Drugs and Cosmetics to Food and Tobacco

Essentials of Pharmacoeconomics: Health Economics and Outcomes Research

Comparative Diagnostic Pharmacology: Clinical and Research Applications in Living-System Models

Cancer Cell Signaling: Targeting Signaling Pathways Toward Therapeutic Approaches to Cancer

Medical Technology and Environmental Health: Proceedings of the Medicine and Global Health Research Symposium (MoRes 2019), 22-23 October 2019, Bandung, Indonesia

Medical Technology and Environmental Health: Proceedings of the Medicine and Global Health Research Symposium (MoRes 2019), 22-23 October 2019, Bandung, Indonesia

The DNP Professional: Translating Value from Classroom to Practice

Biodiversity, Natural Products And Cancer Treatment

Cell-Penetrating Peptides: Methods and Protocols: 1324 (Methods in Molecular Biology, 1324)

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

FDA Regulatory Affairs: Third Edition

The 2007 Import and Export Market for Medicaments Containing Hormones, Their Derivatives, and Other Steriods Used as Hormones Excluding Antibiotics and Their Derivatives in United States

REFORMS IN LEADERSHIP: The 21st Century Mindset Of Transformational Governance in Uganda and Africa

c-di-GMP Signaling: Methods and Protocols: 1657 (Methods in Molecular Biology, 1657)

Defining Drugs: How Government Became the Arbiter of Pharmaceutical Fact

Advanced Mass Spectrometry for Food Safety and Quality (Comprehensive Analytical Chemistry): Volume 68

Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems (Lippincott Connect)

Humana cAMP Signaling: Methods and Protocols 2483 Book

Guide to U.S. Health and Health Care Policy

Advances in Medicine and Medical Research: 1133 (Advances in Experimental Medicine and Biology, 1133)

Advances in Medicine and Medical Research: 1133 (Advances in Experimental Medicine and Biology, 1133)

Reframing Globalization After COVID-19: Pandemic Diplomacy amid the Failure of Multilateral Cooperation

Structure–Activity Relationships for Development of Neurokinin-3 Receptor Antagonists: Reducing Environmental Impact (Springer Theses)